Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.

Salomon MP, Wang X, Marzese DM, Hsu SC, Nelson N, Zhang X, Matsuba C, Takasumi Y, Ballesteros-Merino C, Fox BA, Barkhoudarian G, Kelly DF, Hoon DSB.

Clin Cancer Res. 2018 Sep 1;24(17):4126-4136. doi: 10.1158/1078-0432.CCR-17-2206. Epub 2018 Jul 3.

PMID:
30084836
2.

The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells.

Izraely S, Ben-Menachem S, Sagi-Assif O, Telerman A, Zubrilov I, Ashkenazi O, Meshel T, Maman S, Orozco JIJ, Salomon MP, Marzese DM, Pasmanik-Chor M, Pikarsky E, Ehrlich M, Hoon DSB, Witz IP.

Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31745. [Epub ahead of print]

PMID:
29992556
3.

Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.

Graff-Baker AN, Orozco JIJ, Marzese DM, Salomon MP, Hoon DSB, Goldfarb M.

Ann Surg Oncol. 2018 Oct;25(10):3082-3087. doi: 10.1245/s10434-018-6582-7. Epub 2018 Jun 28.

PMID:
29956094
4.

Alternative splicing and cancer metastasis: prognostic and therapeutic applications.

Marzese DM, Manughian-Peter AO, Orozco JIJ, Hoon DSB.

Clin Exp Metastasis. 2018 May 29. doi: 10.1007/s10585-018-9905-y. [Epub ahead of print]

PMID:
29845349
5.

Distinct histone modifications denote early stress-induced drug tolerance in cancer.

Al Emran A, Marzese DM, Menon DR, Stark MS, Torrano J, Hammerlindl H, Zhang G, Brafford P, Salomon MP, Nelson N, Hammerlindl S, Gupta D, Mills GB, Lu Y, Sturm RA, Flaherty K, Hoon DSB, Gabrielli B, Herlyn M, Schaider H.

Oncotarget. 2017 Dec 24;9(9):8206-8222. doi: 10.18632/oncotarget.23654. eCollection 2018 Feb 2.

6.

ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis.

Izraely S, Ben-Menachem S, Sagi-Assif O, Meshel T, Marzese DM, Ohe S, Zubrilov I, Pasmanik-Chor M, Hoon DSB, Witz IP.

Oncotarget. 2017 Jul 5;8(44):75778-75796. doi: 10.18632/oncotarget.19018. eCollection 2017 Sep 29.

7.

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas.

Fan K, Wang X, Zhang J, Ramos RI, Zhang H, Li C, Ye D, Kang J, Marzese DM, Hoon DSB, Hua W.

Sci Rep. 2017 Aug 1;7(1):7079. doi: 10.1038/s41598-017-07124-9.

8.

The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.

Ruiz R, Jahid S, Harris M, Marzese DM, Espitia F, Vasudeva P, Chen CF, de Feraudy S, Wu J, Gillen DL, Krasieva TB, Tromberg BJ, Pavan WJ, Hoon DS, Ganesan AK.

PLoS Genet. 2017 Jul 28;13(7):e1006913. doi: 10.1371/journal.pgen.1006913. eCollection 2017 Jul.

9.

TP73 DNA methylation and upregulation of ΔNp73 are associated with an adverse prognosis in breast cancer.

Gomez LC, Sottile ML, Guerrero-Gimenez ME, Zoppino FCM, Redondo AL, Gago FE, Orozco JI, Tello OM, Roqué M, Nadin SB, Marzese DM, Vargas-Roig LM.

J Clin Pathol. 2018 Jan;71(1):52-58. doi: 10.1136/jclinpath-2017-204499. Epub 2017 Jul 25.

PMID:
28743687
10.

MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.

Bustos MA, Ono S, Marzese DM, Oyama T, Iida Y, Cheung G, Nelson N, Hsu SC, Yu Q, Hoon DSB.

J Invest Dermatol. 2017 Sep;137(9):1955-1964. doi: 10.1016/j.jid.2017.03.039. Epub 2017 May 16.

11.

CCR4 is a determinant of melanoma brain metastasis.

Klein A, Sagi-Assif O, Meshel T, Telerman A, Izraely S, Ben-Menachem S, Bayry J, Marzese DM, Ohe S, Hoon DSB, Erez N, Witz IP.

Oncotarget. 2017 May 9;8(19):31079-31091. doi: 10.18632/oncotarget.16076.

12.

Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.

Iida Y, Ciechanover A, Marzese DM, Hata K, Bustos M, Ono S, Wang J, Salomon MP, Tran K, Lam S, Hsu S, Nelson N, Kravtsova-Ivantsiv Y, Mills GB, Davies MA, Hoon DSB.

Clin Cancer Res. 2017 Aug 15;23(16):4831-4842. doi: 10.1158/1078-0432.CCR-17-0146. Epub 2017 Apr 7.

13.

Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer.

Bustos MA, Salomon MP, Nelson N, Hsu SC, DiNome ML, Hoon DS, Marzese DM.

Genom Data. 2017 Feb 14;12:14-16. doi: 10.1016/j.gdata.2017.01.002. eCollection 2017 Jun.

14.
15.

Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.

Marzese DM, Witz IP, Kelly DF, Hoon DS.

Epigenomics. 2015;7(8):1303-11. doi: 10.2217/epi.15.77. Epub 2015 Dec 7. Review.

PMID:
26638944
16.

The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching.

Lessard L, Liu M, Marzese DM, Wang H, Chong K, Kawas N, Donovan NC, Kiyohara E, Hsu S, Nelson N, Izraely S, Sagi-Assif O, Witz IP, Ma XJ, Luo Y, Hoon DSB.

J Invest Dermatol. 2015 Oct;135(10):2464-2474. doi: 10.1038/jid.2015.200. Epub 2015 May 27.

17.

Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.

Marzese DM, Hoon DS.

Expert Rev Mol Diagn. 2015 May;15(5):647-64. doi: 10.1586/14737159.2015.1027194. Epub 2015 Mar 22. Review.

18.

Multi-platform Genome-wide Analysis of Melanoma Progression to Brain Metastasis.

Marzese DM, Huynh JL, Kawas NP, Hoon DS.

Genom Data. 2014 Dec 1;2:150-152.

19.

Epigenetic variations in breast cancer progression to lymph node metastasis.

Urrutia G, Laurito S, Marzese DM, Gago F, Orozco J, Tello O, Branham T, Campoy EM, Roqué M.

Clin Exp Metastasis. 2015 Feb;32(2):99-110. doi: 10.1007/s10585-015-9695-4. Epub 2015 Jan 28.

PMID:
25628026
20.

Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.

Hoshimoto S, Takeuchi H, Ono S, Sim MS, Huynh JL, Huang SK, Marzese DM, Kitagawa Y, Hoon DS.

J Thorac Oncol. 2015 Mar;10(3):509-17. doi: 10.1097/JTO.0000000000000441.

21.

RASAL2 activates RAC1 to promote triple-negative breast cancer progression.

Feng M, Bao Y, Li Z, Li J, Gong M, Lam S, Wang J, Marzese DM, Donovan N, Tan EY, Hoon DS, Yu Q.

J Clin Invest. 2014 Dec;124(12):5291-304. doi: 10.1172/JCI76711. Epub 2014 Nov 10.

22.

Epigenetic changes of EGFR have an important role in BRAF inhibitor-resistant cutaneous melanomas.

Wang J, Huang SK, Marzese DM, Hsu SC, Kawas NP, Chong KK, Long GV, Menzies AM, Scolyer RA, Izraely S, Sagi-Assif O, Witz IP, Hoon DSB.

J Invest Dermatol. 2015 Feb;135(2):532-541. doi: 10.1038/jid.2014.418. Epub 2014 Sep 22.

23.

Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.

Marzese DM, Liu M, Huynh JL, Hirose H, Donovan NC, Huynh KT, Kiyohara E, Chong K, Cheng D, Tanaka R, Wang J, Morton DL, Barkhoudarian G, Kelly DF, Hoon DS.

Pigment Cell Melanoma Res. 2015 Jan;28(1):82-93. doi: 10.1111/pcmr.12307. Epub 2014 Sep 30.

24.

DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.

Marzese DM, Scolyer RA, Roqué M, Vargas-Roig LM, Huynh JL, Wilmott JS, Murali R, Buckland ME, Barkhoudarian G, Thompson JF, Morton DL, Kelly DF, Hoon DS.

Neuro Oncol. 2014 Nov;16(11):1499-509. doi: 10.1093/neuonc/nou107. Epub 2014 Jun 26.

25.

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.

Marzese DM, Hirose H, Hoon DS.

Expert Rev Mol Diagn. 2013 Nov;13(8):827-44. doi: 10.1586/14737159.2013.845088. Epub 2013 Oct 16. Review.

PMID:
24127721
26.

Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.

Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, Kiyohara E, Wang J, Kawas NP, Donovan NC, Hata K, Wilmott JS, Murali R, Buckland ME, Shivalingam B, Thompson JF, Morton DL, Kelly DF, Hoon DS.

Hum Mol Genet. 2014 Jan 1;23(1):226-38. doi: 10.1093/hmg/ddt420. Epub 2013 Sep 6.

27.

Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma.

Sato Y, Marzese DM, Ohta K, Huang SK, Sim MS, Chong K, Hoon DS.

Epigenetics. 2013 Oct;8(10):1043-52. doi: 10.4161/epi.25810. Epub 2013 Jul 31.

28.

DNA methylation index and methylation profile of invasive ductal breast tumors.

Marzese DM, Hoon DS, Chong KK, Gago FE, Orozco JI, Tello OM, Vargas-Roig LM, Roqué M.

J Mol Diagn. 2012 Nov;14(6):613-22. doi: 10.1016/j.jmoldx.2012.07.001. Epub 2012 Aug 25.

PMID:
22925694
29.

Methylation profile of triple-negative breast carcinomas.

Branham MT, Marzese DM, Laurito SR, Gago FE, Orozco JI, Tello OM, Vargas-Roig LM, Roqué M.

Oncogenesis. 2012 Jul 2;1:e17. doi: 10.1038/oncsis.2012.17.

30.

Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report.

Marzese DM, Gago FE, Orozco JI, Tello OM, Roqué M, Vargas-Roig LM.

J Med Case Rep. 2011 Oct 18;5:516. doi: 10.1186/1752-1947-5-516.

31.

Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA.

Marzese DM, Gago FE, Vargas-Roig LM, Roqué M.

Mol Cell Probes. 2010 Oct;24(5):271-80. doi: 10.1016/j.mcp.2010.05.002. Epub 2010 Jun 16.

PMID:
20561583
32.

Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion.

Ferreiro V, Giliberto F, Muñiz GM, Francipane L, Marzese DM, Mampel A, Roqué M, Frechtel GD, Szijan I.

Muscle Nerve. 2009 Feb;39(2):239-43. doi: 10.1002/mus.21193.

PMID:
19012301
33.

MLPA mutation detection in Argentine HNPCC and FAP families.

Gomez LC, Marzese DM, Adi J, Bertani D, Ibarra J, Mol B, Vos IJ, De Marchi G, Roqué M.

Fam Cancer. 2009;8(1):67-73. doi: 10.1007/s10689-008-9200-1. Epub 2008 Jul 10.

PMID:
18615272
34.

Detection of deletions and duplications in the Duchenne muscular dystrophy gene by the molecular method MLPA in the first Argentine affected families.

Marzese DM, Mampel A, Gomez LC, Echeverria MI, Vargas AL, Ferreiro V, Giliberto F, Roqué M.

Genet Mol Res. 2008 Mar 11;7(1):223-33.

PMID:
18393226
35.

Development of a Premature Stop Codon-detection method based on a bacterial two-hybrid system.

Real SM, Marzese DM, Gomez LC, Mayorga LS, Roqué M.

BMC Biotechnol. 2006 Sep 2;6:38.

Supplemental Content

Loading ...
Support Center